X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs AJANTA PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS AJANTA PHARMA J.B.CHEMICALS/
AJANTA PHARMA
 
P/E (TTM) x 17.4 21.8 80.0% View Chart
P/BV x 2.2 4.1 53.3% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 J.B.CHEMICALS   AJANTA PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
AJANTA PHARMA
Mar-18
J.B.CHEMICALS/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3631,818 20.0%   
Low Rs2551,106 23.1%   
Sales per share (Unadj.) Rs169.1239.5 70.6%  
Earnings per share (Unadj.) Rs16.652.8 31.4%  
Cash flow per share (Unadj.) Rs23.459.5 39.4%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs172.5230.0 75.0%  
Shares outstanding (eoy) m83.5788.77 94.1%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.86.1 29.9%   
Avg P/E ratio x18.627.7 67.2%  
P/CF ratio (eoy) x13.224.6 53.7%  
Price / Book Value ratio x1.86.4 28.2%  
Dividend payout %12.00-   
Avg Mkt Cap Rs m25,827129,782 19.9%   
No. of employees `0003.86.8 55.5%   
Total wages/salary Rs m2,5113,765 66.7%   
Avg. sales/employee Rs Th3,747.43,128.4 119.8%   
Avg. wages/employee Rs Th665.7554.0 120.2%   
Avg. net profit/employee Rs Th367.8689.7 53.3%   
INCOME DATA
Net Sales Rs m14,13521,258 66.5%  
Other income Rs m366242 151.4%   
Total revenues Rs m14,50121,499 67.4%   
Gross profit Rs m2,1786,584 33.1%  
Depreciation Rs m570596 95.6%   
Interest Rs m354 851.2%   
Profit before tax Rs m1,9406,226 31.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5521,539 35.9%   
Profit after tax Rs m1,3874,686 29.6%  
Gross profit margin %15.431.0 49.8%  
Effective tax rate %28.524.7 115.2%   
Net profit margin %9.822.0 44.5%  
BALANCE SHEET DATA
Current assets Rs m10,47012,236 85.6%   
Current liabilities Rs m2,7493,461 79.4%   
Net working cap to sales %54.641.3 132.3%  
Current ratio x3.83.5 107.7%  
Inventory Days Days5560 91.7%  
Debtors Days Days7884 91.9%  
Net fixed assets Rs m5,81111,140 52.2%   
Share capital Rs m167177 94.5%   
"Free" reserves Rs m14,24820,237 70.4%   
Net worth Rs m14,41620,414 70.6%   
Long term debt Rs m010 0.0%   
Total assets Rs m17,64924,486 72.1%  
Interest coverage x56.61,519.4 3.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.9 92.3%   
Return on assets %8.119.2 42.1%  
Return on equity %9.623.0 41.9%  
Return on capital %13.730.5 44.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16411,667 52.8%   
Fx outflow Rs m1,3341,616 82.6%   
Net fx Rs m4,82910,052 48.0%   
CASH FLOW
From Operations Rs m1,2312,854 43.1%  
From Investments Rs m-208-2,604 8.0%  
From Financial Activity Rs m-595-2 29,760.0%  
Net Cashflow Rs m427248 172.1%  

Share Holding

Indian Promoters % 55.4 73.8 75.1%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 1.6 218.7%  
FIIs % 3.9 7.6 51.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 17.0 217.6%  
Shareholders   30,437 20,968 145.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   CADILA HEALTHCARE  TTK HEALTHCARE  MERCK  DISHMAN PHARMA  FULFORD INDIA  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Jet Airways and Yes Bank - What's Next for these Beaten Down Stocks?(Podcast)

Jet Airways and Yes Bank, both once market darlings are now being shunned by market participants. The National Stock Exchange (NSE) exchange notified that the shares of the airline.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

AJANTA PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 54.6% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, AJANTA PHARMA has posted a net profit of Rs 669 m (down 54.6% YoY). Sales on the other hand came in at Rs 5 bn (down 17.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 4.9% YoY). Sales on the other hand came in at Rs 5 bn (up 0.7% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

The Best 4 Small-cap Stocks to Buy(The 5 Minute Wrapup)

Jun 3, 2019

In the sometimes good sometimes bad market of small caps, there are strong buying opportunities available today. But this great opportunity won't last forever.

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Top 7 Stocks to Profit from Modi's Repeat Performance(Profit Hunter)

Jun 3, 2019

The long-term India story looks promising with the Modi government back in power. Which stocks are likely to go up the most?

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 14, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS